Zhejiang Hisun Pharmaceutical Co Ltd (600267) — Cash Flow Reinvestment Rate
Zhejiang Hisun Pharmaceutical Co Ltd (600267) has a Cash Flow Reinvestment Rate of 0.23x as of September 2025, reinvesting CN¥102.69 Million (capex CN¥102.69 Million ) from operating cash flow of CN¥438.43 Million. Check Zhejiang Hisun Pharmaceutical Co Ltd (600267) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Zhejiang Hisun Pharmaceutical Co Ltd Cash Flow Reinvestment Rate (1999–2025)
Historical reinvestment intensity for Zhejiang Hisun Pharmaceutical Co Ltd across 27 annual periods. Explore Zhejiang Hisun Pharmaceutical Co Ltd (600267) investment intensity to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Zhejiang Hisun Pharmaceutical Co Ltd (1999–2025)
Year-by-year capital reinvestment analysis for Zhejiang Hisun Pharmaceutical Co Ltd. For live market cap and broader valuation context, see Zhejiang Hisun Pharmaceutical Co Ltd market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.22x | CN¥443.14 Million | CN¥2.03 Billion | CN¥376.40 Million | ▲ +76.9% |
| 2024 | 0.12x | CN¥260.70 Million | CN¥2.11 Billion | CN¥238.44 Million | ▼ -67.7% |
| 2023 | 0.38x | CN¥578.74 Million | CN¥1.52 Billion | CN¥240.04 Million | ▼ -29.0% |
| 2022 | 0.54x | CN¥1.11 Billion | CN¥2.07 Billion | CN¥530.62 Million | ▲ +29.1% |
| 2021 | 0.42x | CN¥722.31 Million | CN¥1.74 Billion | CN¥622.38 Million | ▼ -64.7% |
| 2020 | 1.18x | CN¥1.87 Billion | CN¥1.59 Billion | CN¥692.04 Million | ▼ -25.1% |
| 2019 | 1.57x | CN¥1.10 Billion | CN¥698.39 Million | CN¥1.08 Billion | ▲ +22.1% |
| 2018 | 1.29x | CN¥1.86 Billion | CN¥1.45 Billion | CN¥1.60 Billion | ▲ +3.5% |
| 2017 | 1.25x | CN¥1.54 Billion | CN¥1.24 Billion | CN¥1.46 Billion | ▼ -67.9% |
| 2016 | 3.88x | CN¥3.01 Billion | CN¥775.90 Million | CN¥1.77 Billion | ▲ +23.6% |
| 2015 | 3.14x | CN¥2.31 Billion | CN¥736.17 Million | CN¥1.93 Billion | ▼ -17.0% |
| 2014 | 3.78x | CN¥2.16 Billion | CN¥571.04 Million | CN¥2.16 Billion | ▼ -6.1% |
| 2013 | 4.02x | CN¥2.12 Billion | CN¥527.25 Million | CN¥2.12 Billion | ▼ -7.4% |
| 2012 | 4.34x | CN¥1.63 Billion | CN¥375.75 Million | CN¥1.63 Billion | ▲ +76.4% |
| 2011 | 2.46x | CN¥1.29 Billion | CN¥525.31 Million | CN¥1.29 Billion | ▲ +52.4% |
| 2010 | 1.62x | CN¥823.08 Million | CN¥509.18 Million | CN¥823.08 Million | ▼ -11.3% |
| 2009 | 1.82x | CN¥861.67 Million | CN¥472.85 Million | CN¥861.67 Million | ▼ -37.8% |
| 2008 | 2.93x | CN¥648.25 Million | CN¥221.28 Million | CN¥648.25 Million | ▲ +309.2% |
| 2007 | 0.72x | CN¥313.34 Million | CN¥437.72 Million | CN¥313.34 Million | ▼ -75.5% |
| 2006 | 2.92x | CN¥315.67 Million | CN¥108.03 Million | CN¥315.67 Million | ▲ +23.4% |
| 2005 | 2.37x | CN¥268.75 Million | CN¥113.53 Million | CN¥268.75 Million | ▲ +137.0% |
| 2004 | 1.00x | CN¥312.52 Million | CN¥312.93 Million | CN¥312.52 Million | ▲ +13.5% |
| 2003 | 0.88x | CN¥253.90 Million | CN¥288.45 Million | CN¥253.90 Million | ▼ -56.3% |
| 2002 | 2.01x | CN¥243.39 Million | CN¥120.82 Million | CN¥243.39 Million | ▼ -47.5% |
| 2001 | 3.84x | CN¥265.33 Million | CN¥69.14 Million | CN¥265.33 Million | ▲ +5.4% |
| 2000 | 3.64x | CN¥202.76 Million | CN¥55.70 Million | CN¥202.76 Million | ▼ -0.3% |
| 1999 | 3.65x | CN¥119.23 Million | CN¥32.64 Million | CN¥119.23 Million | — |